baber/WOPTO huggingface dataset:
Patent ES-2228028-T3 (ES)
Title: Derivados de acido 2-metilpropionico y composiciones medicinales que los contienen.
Inventor: TAMAI TETSURO
IPC: C07C229/18
Filed: 1999-04-07
Granted: 2005-04-01
Abstract: Un derivado del ácido 2-metilpropiónico representado por la fórmula general: en la que R1 representa un átomo de hidrógeno, un grupo alquilo lineal o ramificado que tiene de 1 a 6 átomos de carbono o un grupo aralquilo; R2 representa un átomo de hidrógeno, un grupo alquilo lineal o ramificado que tiene de 1 a 6 átomos de carbono o un átomo de halógeno; A representa un átomo de oxígeno o un grupo imino; el átomo de carbono marcado con (R) representa un átomo de carbono en configuración R; y el átomo de carbono marcado con (S) representa un átomo de carbono en configuración S, o una sal farmacéuticamente aceptable del mismo.
Patent ES-2201720-T3 (ES)
Inventor: SUNJIC VITOMIR
IPC: C07C255/58
Filed: 1999-04-28
Granted: 2004-03-16
Abstract: The present invention describes new chiral stationary phases and optically active compounds therein contained. The optically active compounds contained in the stationary phases are represented by the formula of structure (I), containing at least one asymmetric carbon atom, and a substituent acting as a spacer. The stationary phases of the present invention are useful in the preparation of chromatographic columns useful for the separation of enantiomers.
Patent ES-2291028-T3 (ES)
Inventor: DUTTON PETER
IPC: H01R13/00
Filed: 1999-05-27
Granted: 2008-02-16
Abstract: The present electrical connector assembly includes an outer shell capable of receiving at least one electrical contact module. The outer shell works in cooperation with an improved contact module retaining device which secures the electrical contact module within the shell. The combination of the outer shell with the contact module retaining device protects the critical elements of the retaining device from exterior environments, does not interfere with insertion of the module into the shell, and provides for a precise alignment of the module during and after insertion of the module into the shell. In particular, the outer shell is comprised of two half shells which are open during attachment of a contact module retaining device to each of the half shells. The two half shells are joined to form a connector housing after attachment of the module retaining device. The preferred module retaining device is a clip which is attached so that the main body of the clip is in contact with an interior surface of the half shell. The clip is precisely aligned within the half shell using snap fit contacts which hold the clip in position until the half shells are joined, after which the clips may be held in position by contact with the interior surface of the half shell alone.
Patent ES-2293736-T3 (ES)
Inventor: CARLSSON JAN
IPC: G01N33/558
Filed: 1999-04-30
Granted: 2008-03-16
Abstract: The invention relates to a method for determining the binding capability of a structure (ligand) to an analyte, which method comprises:  i. applying the sample to an application zone for sample (ASZ) on a flow matrix in which transport of components present in the sample may take place (transport flow), the flow matrix further comprising:  a) optionally an application zone (AR*Z) for a binding reactant (Reactant* = R*) which is analytically detectable, b) a detection zone (DZ) which is located downstream of ASZ and comprises another binding reactant (Capturer) firmly anchored to the matrix and in which a complex (signal complex) containing the Capturer and the analyte and/or Reactant* is formed during the method, and  ii. detecting the signal complex in the detection zone, the measured signal being used for determining the analyte,  wherein the flow matrix comprises at least one separation zone (SZ) between ASZ and DZ and this zone (SZ) exhibits a structure (ligand) having binding capability for the analyte, and the binding capability of the ligand for the analyte is determined. According to the invention, the flow matrix comprises at least one separation zone (SZ) between ASZ and DZ, which zone exhibits a structure (ligand) having binding capability for the analyte that is transported in the matrix. The invention also relates to a test kit comprising the flow matrix. <IMAGE>
Patent ES-2238855-T3 (ES)
Title: Dispositivos de administracion de fluidos atraumaticos.
Inventor: DIVINO VINCENT JR
IPC: A61M31/00
Filed: 1999-06-04
Granted: 2005-09-01
Abstract: Dispositivo de administración de fluidos que comprende: un alojamiento (12, 30, 46) tubular generalmente dispuesto a lo largo de un eje longitudinal que tiene extremos proximal y distal y una pared de alojamiento que define una luz (14) de fluido central que comunica con orificios (44) laterales en al pared de alojamiento; caracterizado por un medio (42) para dirigir axialmente el fluido que sale de dichos orificios (44) laterales, en el que dicho medio (42) para dirigir axialmente el fluido comprende al menos una vaina (42) tubular dispuesta alrededor de dicho alojamiento (12, 30, 46) tubular para definir un paso de fluido entre el alojamiento (12, 30, 46) tubular y dicha vaina (42) tubular, y en el que la vaina (42) está sellada en un extremo y proporciona una abertura en el extremo opuesto que comunica con dicha vía de paso.
Patent ES-2313797-T3 (ES)
Title: Composicion de metilfenidato de liberacion modificada multiparticulada.
Inventor: DEVANE JOHN G
IPC: A61K9/48
Filed: 1999-11-01
Granted: 2009-03-01
Abstract: Una composición de liberación modificada multi-particulada que contiene fenidato de metilo y que tiene un primer componente que comprende una primera población de partículas que contienen fenidato de metilo y al menos un componente subsiguiente, comprendiendo cada componente subsiguiente una población subsiguiente de partículas que contienen fenidato de metilo; en la que al menos una población subsiguiente de las partículas que contienen fenidato de metilo comprende además un revestimiento de liberación modificada o, alternativamente o adicionalmente, un material matriz de liberación modificada, de tal manera que la composición después de su suministro por vía oral a un sujeto suministra el fenidato de metilo de una manera pulsátil, de tal manera que se producen períodos de elevadas concentraciones de fenidato de metilo en el plasma sanguíneo intercalados con períodos de bajas concentraciones de fenidato de metilo en el plasma sanguíneo, en la que los períodos de bajas concentraciones en el plasma sanguíneo proporcionan el arrastre del fenidato de metilo.
Patent ES-2189523-T3 (ES)
Title: Alquilacion enantioselectiva de compuestos triciclicos.
Inventor: KUO SHEN-CHUN
IPC: C07D401/04
Filed: 1999-11-18
Granted: 2003-07-01
Abstract: Un procedimiento para preparar un compuesto de la fórmula: **(Fórmula)** en la que X1, X2, X3, X4, y X5 se seleccionan independientemente del grupo que consiste en H, halo, alquilo, alcoxi, arilo y ariloxi, y R es un grupo protector, comprendiendo dicho procedimiento: tratar un compuesto que tiene la fórmula**(Fórmula)** en la que X1, X2, X3, X4, y X5 son como se definen anteriormente, con los siguientes, en cualquier orden: (a) una base fuerte no nucleófila; (b) un aminoalcohol quiral; y (c) un compuesto que tiene la fórmula **(Fórmula)** en la que L es un grupo saliente y R es como se define anteriormente.
Patent ES-2289833-T3 (ES)
Title: Nuevo metodo de tratamiento.
Inventor: BENINCOSA LISA
IPC: A61K31/426
Filed: 1999-11-12
Granted: 2008-02-01
Abstract: Una composición farmacéutica de liberación sostenida en forma de dosificación unitaria y destinada a administración oral que comprende 2 a 12 mg de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidina-2, 4-diona o una sal o un solvato farmacéuticamente aceptable del mismo y un vehículo farmacéiticamente aceptable para el mismo, dosificación que proporciona una concentración plasmática de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidina-2, 4-diona de al menos 50 ng/ml a lo largo de un período de hasta 24 horas.
Patent PL-1454568-T3 (PL)
Title: Chair, particularly office-chair
Inventor: ELZENBECK MANFRED
IPC: A47C1/024
Filed: 2004-03-02
Abstract: The chair is equipped with a seat carrying construction assembled of a swivel mounted front (6) and rear part. The seat can be adjusted regarding its level of inclination with a spring (27, 28), adjustable in length and swivel mounted between front (6) and rear part. The distance between the spring (27, 28) and the swivel axle is controlled with a rotating handle (42). The handle (42) is joined with a coupling element (39,40) designed as a bevel gear unit to the control device (36) resulting of the axles of the handle (42) and the control device (36) forming an angle.
Patent PL-1737681-T3 (PL)
Title: Process for manufacturing a light alloy wheel rim and wheel rim resulting therefrom
Inventor: AFELTRA UMBERTO
IPC: B60B3/02
Filed: 2004-04-23
Abstract: Process for manufacturing a wheel rim in light alloy including the following operations: providing a rough wheel rim in light alloy, comprising a wheel disc and an annular portion, the annular portion including a first and a second bead defining a drop well having a first profile; processing the rough wheel rim, modifying the first profile in order to obtain a second profile being of a lower thickness than the first profile, at least at an intermediate portion of the drop well, characterised by including a finishing operation of a surface of the second profile intermediate portion by means of a compression action of said surface, the finishing operation leaving the low thickness substantially unchanged.
Patent PL-1644381-T3 (PL)
Title: Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
Inventor: KOTAY NAGY Péter
IPC: C07D495/04
Filed: 2004-06-30
Abstract: Preparation of the polymorph form 1 of clopidogrel hydrogensulfate (I) comprises dissolving clopidogrel base in an A type solvent, adding sulfuric acid and/or A or B type solvent, the obtained mixture containing clopidogrel hydrogensulfate is added to a mixture of a B type solvent containing clopidogrel hydrogensulfate polymorph form 1 as a suspension and filtering, optionally washing and drying the formed precipitate. Preparation of the polymorph form 1 of methyl (S)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate of formula (I) comprises (a) dissolving clopidogrel base in an A type solvent, adding sulfuric acid or a mixture of sulfuric acid and an A or B type solvent to the mixture, the obtained mixture containing clopidogrel hydrogensulfate is added to a mixture of a B type solvent containing clopidogrel hydrogensulfate polymorph form 1 as a suspension; or (b) dissolving clopidogrel base in a mixture of A and B type solvents, clopidogrel hydrogensulfate polymorph form 1 is added to the solution, then adding sulfuric acid or a mixture of sulfuric acid with an A or B type solvent to the obtained mixture; and (c) filtering, optionally washing and drying the formed precipitate. [Image].
Patent PL-1713335-T3 (PL)
Title: Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the methionine biosynthesis
Inventor: GOUOT JEAN-MARIE
IPC: A01N43/40
Filed: 2005-02-10
Abstract: A composition comprising at least a pyridylethylbenzamide derivative of general formula (I) (a) and a compound capable of inhibiting the methionine biosynthesis (b) in a (a) / (b) weight ratio of from 0.01 to 20. <??>A composition further comprising an additional fungicidal compound. <??>A method for preventively or curatively combating the phytopathogenic fungi of crops by using this composition.
Patent PL-1833473-T3 (PL)
Title: 5ht2c receptor modulator compositions and methods of use
Inventor: BEHAN DOMINIC P
IPC: A61P3/04
Filed: 2005-12-21
Abstract: The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. The compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.
Patent PL-1843778-T3 (PL)
Title: Compositions comprising epigallocatechin gallate and protein hydrolysate
Inventor: WOLFRAM SWEN
IPC: A61K38/01
Filed: 2006-02-02
Abstract: The present invention describes a composition comprising EGCG and a protein hydrolysate.
Patent PL-1941092-T3 (PL)
Title: A needled belt with high thickness and elasticity
Inventor: CASSARINO GIANCARLO
IPC: D06C21/00
Filed: 2006-09-01
Abstract: A multi-base needled belt having an elastic surface comprising a conventional base layer, an elastic base layer and at least two batt layers needled into both base layers in order to join the base layers to each other, wherein the belt's elasticity derives from elastic fibers that are used to construct the elastic layer.
Patent PL-1989218-T3 (PL)
Title: 17-phosphorous steroid derivatives useful as progesterone receptor modulators
Inventor: JIANG WEIQIN
IPC: C07J51/00
Filed: 2007-02-16
Abstract: The present invention is directed to novel 17-phosphorous steroid derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by a progesterone or glucocorticoid receptor.
Patent PL-2183145-T3 (PL)
Title: Shock-proof device for the front or rear region of a track-guided vehicle having at least one energy consumption device
Inventor: MATTSCHULL VOLKER
IPC: B61D15/06
Filed: 2008-09-05
Abstract: The invention relates to an energy absorption device as part of a shock absorber for the front or rear region of a railborne vehicle, in particular a streetcar vehicle, wherein the energy absorption device is designed to absorb or dissipate at least a portion of the impact energy which occurs when the vehicle impacts an obstacle. The invention includes a bumper bar which is pivotably connected to the vehicle underframe by a first bearing, a pendulum support connected to the bumper bar by a second bearing and to the vehicle underframe by a third bearing such that the bumper bar and pendulum support form a tripod. The resultant moment of force of the bumper bar pivoting about a pivot axis defined by a first bearing is introduced as linear force into the energy-absorbing mechanism and at least partly absorbed or dissipated there.
Patent PL-2068307-T3 (PL)
Title: Enhanced coding and parameter representation of multichannel downmixed object coding
Inventor: ENGDEGARD JONAS
IPC: G10L19/00
Filed: 2007-10-05
Abstract: An audio object coder for generating an encoded object signal using a plurality of audio objects includes a downmix information generator for generating downmix information indicating a distribution of the plurality of audio objects into at least two downmix channels, an audio object parameter generator for generating object parameters for the audio objects, and an output interface for generating the imported audio output signal using the downmix information and the object parameters. An audio synthesizer uses the downmix information for generating output data usable for creating a plurality of output channels of the predefined audio output configuration.
Patent PL-2133203-T3 (PL)
Title: Multi-layer optical film constructions with improved characteristics and use thereof
Inventor: PUDLEINER HEINZ
IPC: B32B27/36
Filed: 2009-05-30
Abstract: Film structure comprises at least one prism film and/or a diffuser film and a multilayer optical film exhibiting at least a cover film having an outer layer directed to the prism film and/or diffuser film, where the outer layer: is made of a plastic composition having a transparent thermoplastic compound and a quaternary ammonium salt of perfluoroalkyl sulfonic acid as lubricant-additive; and has a sliding friction coefficient of less than 0.30 for prism- or diffuser film, according to ASTM D 1894-06, at a roughness of R3z greater than 5 mu m according to the standard ISO 4288.
Patent GR-3000848-T3 (GR)
Title: Process for the production of explosive cartridges, and explosive carbridges obtained thereby
Inventor: BOUILLET EDMOND
IPC: C06B21/00
Filed: 1990-09-20
Abstract: PCT No. PCT/BE87/00008 Sec. 371 Date Nov. 29, 1988 Sec. 102(e) Date Nov. 29, 1988 PCT Filed May 21, 1987 PCT Pub. No. WO87/07258 PCT Pub. Date Dec. 3, 1987.A process for the manufacture of an explosive cartridge in a tubular casing, including mixing a solution containing hydrogen peroxide, an oxidizable organic material, and at least one precursor monomer of a gelling agent; and reacting the at least one precursor monomer to form macromolecules of the gelling agent in situ in the tubular casing.
Patent GR-3004097-T3 (GR)
IPC: C04B41/00
Filed: 1992-03-19
Abstract: In order to seal protective constructions made of concrete against organic liquids, the concrete mixture is admixed with an organic additive comprising a thermoplastic, for example polystyrene, which, with the organic liquid, for example a chlorinated hydrocarbon, naphtha, toluene or xylene, acting on the concrete construction, forms a highly viscous material which seals the pores of the setting concrete.
Patent GR-3005094-T3 (GR)
IPC: A61K31/66
Filed: 1992-07-02
Abstract: The use of 3-(aminopropyl)methyl phosphinic acid as a potent selective GABAB receptor agonist, pharmaceutical compositions containing it, and its use in therapy, in particular in the treatment of central nervous system disorders.
Patent GR-3018220-T3 (GR)
Title: Artificial promoter for protein expression in yeast.
Inventor: LEPLATOIS PASCAL
IPC: C07K14/815
Filed: 1995-11-29
Abstract: An artificial promoter for expressing proteins in yeast, comprising a sub-sequence upstream from the TATA element of the Saccharomyces cerevisiae gene GAL7 promoter sequence, which comprises the upstream activating sequences UAS1 and UAS2; and a sub-sequence of an ADH2 promoter sequence comprising the TATA element and the transcription initiating region. Uses include obtaining proteins, oxidase urate in particular.
Patent GR-3020331-T3 (GR)
Title: Process for treating rare earth sulfide pigments, thus obtained pigments and their use.
Inventor: MACAUDIERE PIERRE
IPC: C09C1/62
Filed: 1996-06-24
Abstract: The invention relates to a process for the treatment of pigments based on rare-earth sesquisulphides, aimed more particularly at improving the colour of the latter, the said process being characterised in that it consists in subjecting the said pigments to a fluoridation treatment allowing fluorine atoms to be incorporated, preferably at the surface, within the said pigments. The invention also relates to new pigments based on rare-earth sesquisulphides with improved chromatic properties and characterised essentially in that they contain fluorine atoms, preferably at the surface. These fluoridised pigments may furthermore take an encapsulated form, preferably in silica. The invention finally relates to the use of the said pigments for colouring various materials, in particular plastics.
Patent GR-3022629-T3 (GR)
Title: Process for the production of alkyle (meth)acrylates by direct esterification.
Inventor: FAUCONET MICHEL
IPC: C07C67/58
Filed: 1997-02-21
Abstract: An alkyl (meth)acrylate is prepared by a direct esterification (in 1) of (meth)acrylic acid by the corresponding alcohol, catalysed by H2SO4. The crude reaction mixture (B1), comprising the targeted ester, alcohol, (meth)acrylic acid, alkyl acid sulphate (alkyl hydrogen sulphate) and traces of H2SO4, is treated (in 3) with a base in order to neutralise the acid species, the resulting salts passing into the aqueous phase (A1), which is separated from the organic phase (O1) containing the targeted ester. The light products (L1), containing the alcohol, are recovered (in 4) from the aqueous phase and the waste water (E2) is discarded. The alkyl acid sulphate present in the aqueous phase (A1) resulting from the separation carried out after the neutralisation (in 3) is hydrolysed (in 8) to form, in this phase, alcohol and H2SO4, the acid species resulting from the hydrolysis are neutralised by introduction into the medium of a base and the resulting aqueous phase (A3) is sent to the alcohol recovery stage. Pollution of the waste water (E2), attributable to the alkyl acid sulphate, is thus avoided. <IMAGE>
Patent GR-3023086-T3 (GR)
Title: Controlled release verapamil tablet
Inventor: BAICHWAL ANAND R
IPC: A61K9/20
Filed: 1997-04-09
Abstract: Controlled release verapamil tablets are disclosed. The tablets include an excipient having a hydrophilic material, preferably containing a mixture of xanthan gum/locust bean gum, and an inert diluent.
Patent GR-3023775-T3 (GR)
Title: Pourable liquid aqueous cleaning-agent concentrates (ii)
Inventor: JESCHKE RAINER
IPC: C11D17/00
Filed: 1997-06-12
Abstract: PCT No. PCT/EP94/01816 Sec. 371 Date Dec. 11, 1995 Sec. 102(e) Date Dec. 11, 1995 PCT Filed Jun. 3, 1994 PCT Pub. No. WO94/29418 PCT Pub. Date Dec. 22, 1994Pourable, liquid, aqueous cleaning concentrates comprising a) at least about 10% by weight of at least one water soluble abrasive; and b) from about 2 to about 30% by weight of a mixture of narrow-range alkyl polyglycol ethers, amphoteric surfactants and soap, the ratio by weight of amphoteric surfactants to narrow-range alkyl polyglycol ethers being 1:10 to 3:1, the ratio by weight of amphoteric surfactants to soap being 15:1 to 1:3 and the ratio by weight of narrow-range alkyl polyglycol ethers to soap being 25:1 and 1:1.\!
Patent GR-3031066-T3 (GR)
Title: Agent for treating hepato biliary diseases
Inventor: UENO RYUJI
IPC: C07C405/00
Filed: 1999-08-25
Abstract: The object of the present invention is to provide a pharmaceutical composition for treatment of hepato.biliary disease reduced in side effect such as diarrhea, which comprises 16,16-difluoro-15-keto-PGs having at least one methyl group or ethyl group on the carbon atom at the 17- or 18-position or adjacent to the terminal methyl group of omega -chain as an essential component.
Patent GR-3032325-T3 (GR)
Title: Method and composition for ameliorating the adverse effects of aging
Inventor: RATTAN SURESH I S
IPC: A61K/
Filed: 2000-01-07
Abstract: Ameliorating the adverse effects of ageing on mammalian cells comprises; contacting the cells with a compsn. that contains a 6-(substd. amino) purine cytokinin in a concn. sufficient to ameliorate the adverse effects of ageing. The rate of development of characteristics of ageing is reversed or slowed, and the growth rate and total proliferative capacity of the cells, after contact with the compsn., is the same as prior to contact. Pref. the cytokinin is of formula (I). In (I) R1 = furfuryl, phenyl, benzyl, 4-6C n-alkyl, cyclohexylmethyl, (3-hydroxymethyl-3-methyl)allyl or 3,3-dimethylallyl. (I) is most esp. furfuryladenine (kinetin).
Patent GR-3032988-T3 (GR)
Title: Thermoplastic structural system and components therefor and method of making same.
Inventor: DE ZEN VITTORIO
IPC: E04F17/08
Filed: 2000-03-17
Abstract: A thermoplastic wall forming member (14') is provided with rails (39) for securing a wiring channel (40) interiorly of a hollow wall structure to be formed by the wall forming member and other wall forming members.
Patent GR-3033395-T3 (GR)
Title: Fabricless belt
Inventor: KLUMB WERNER
IPC: F16G1/08
Filed: 2000-05-11
Abstract: PCT No. PCT/CH96/00425 Sec. 371 Date May 28, 1989 Sec. 102(e) Date May 28, 1998 PCT Filed Dec. 3, 1996 PCT Pub. No. WO97/21938 PCT Pub. Date Jun. 19, 1997A fabric-free belt has an oriented polyamide layer (1) as a tension layer. A rubber layer (2, 3) is arranged in the form of a laminate on both sides of the oriented polyamide layer (1). The rubber layers (2, 3) contain at least 1 part by weight, based on 100 parts by weight of rubber, of resorcinol, phenol, cresols or mixtures thereof and adhere directly to the oriented polyamide layer (1). An advantage of the invention is that no adhesion promoter coating has to be applied to the polyamide layer (1) or to the rubber layers (2, 3) for the production of the laminate.